Authors: MALAMOS N KOSMAS C ANTONOPOULOS MJ TSIKKINIS A PALLIS L PAPADIAMANTIS J KOURI E VASILAROS S

Citation: N. Malamos et al., PROSPECTIVE RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY (NACT) WITH PACLITAXEL EPIRUBICIN (PE) VERSUS FLUOROURACIL/EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC) IN OPERABLE STAGE II-IIIA BREAST-CANCER (BC)/, Annals of oncology, 9, 1998, pp. 105-105

Authors: KOSMAS C TSAVARIS N POLYZOS A SEPSAS E MALAMOS N KALOFONOS HP PANOPOULOS C ANTONOPOULOS MJ

Citation: C. Kosmas et al., PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 449-449

Authors: KOSMAS C MALAMOS NA ANTONOPOULOS MJ

Citation: C. Kosmas et al., TREATMENT OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 339(20), 1998, pp. 1476-1476